secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001437749-26-004726
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences enters $60M ATM equity distribution agreement with TD Cowen; terminates prior ATM
--------------------------------------------------------------------------------

- Entered equity distribution agreement with TD Cowen to sell up to $59,976,196 of common stock via ATM offerings.
- Terminated prior distribution agreement from July 2024 which had $59,976,196 unsold remaining.
- TD Cowen will receive a 3% commission on gross sales; Company reimburses certain expenses.
- Sales may occur at market prices; Company not obligated to sell any shares.
- No specific use of proceeds disclosed; Company may sell shares from time to time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/0001437749-26-004726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/plse20260218_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer